Literature DB >> 10785842

Cardiovascular autonomic dysfunction in parkinsonian patients.

C J Mathias1.   

Abstract

Cardiovascular dysfunction may occur in parkinsonian patients for a variety of reasons. Patients usually are more than 50 years old and on various drugs (both antiparkinsonian and for associated medical disorders), some of which may have cardiovascular effects. Autonomic failure increases with age and also is recognized in parkinsonian patients who have the disorder multiple system atrophy, in which there is substantial cardiovascular dysfunction. Thus, recognition of cardiovascular dysfunction and its causes in parkinsonian patients is of importance in diagnosis (in separating the various parkinsonian diseases), in determining prognosis, and finally in management. This article outlines the major areas of cardiovascular dysfunction, including disorders of blood pressure control, heart rate, and regional circulation, especially to vital organs. Clinical features and evaluation are described, together with abnormalities in different parkinsonian disorders and the principles of management.

Entities:  

Mesh:

Year:  1998        PMID: 10785842

Source DB:  PubMed          Journal:  Clin Neurosci        ISSN: 1065-6766


  9 in total

Review 1.  Role of autonomic evaluation in the diagnosis and management of syncope.

Authors:  Christopher J Mathias
Journal:  Clin Auton Res       Date:  2004-10       Impact factor: 4.435

2.  Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes.

Authors:  C Friedrich; H Rüdiger; C Schmidt; B Herting; S Prieur; S Junghanns; K Schweitzer; C Globas; L Schöls; D Berg; H Reichmann; T Ziemssen
Journal:  J Neural Transm (Vienna)       Date:  2008-09-20       Impact factor: 3.575

Review 3.  Dysautonomia in Parkinson disease.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

4.  Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension.

Authors:  I F Hussain; C M Brady; M J Swinn; C J Mathias; C J Fowler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

5.  Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype.

Authors:  Paolo Solla; Christian Cadeddu; Antonino Cannas; Martino Deidda; Nicola Mura; Giuseppe Mercuro; Francesco Marrosu
Journal:  J Neural Transm (Vienna)       Date:  2015-03-24       Impact factor: 3.575

6.  Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline.

Authors:  Zaid A Abassi; Ofer Binah; Moussa B H Youdim
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

7.  Age and duration related changes in muscle sympathetic nerve activity in Parkinson's disease.

Authors:  K Shindo; H Watanabe; H Tanaka; K Ohashi; T Nagasaka; S Tsunoda; Z Shiozawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

8.  Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys.

Authors:  Valerie Joers; Kailie Seneczko; Nichole C Goecks; Timothy J Kamp; Timothy A Hacker; Kevin G Brunner; Jonathan W Engle; Todd E Barnhart; R Jerome Nickles; James E Holden; Marina E Emborg
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

9.  Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates.

Authors:  Valerie Joers; Kristine Dilley; Shahrose Rahman; Corinne Jones; Jeanette Shultz; Heather Simmons; Marina E Emborg
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.